General Considerations for Dosing in Special Populations. Dosage for Patients with Renal Impairment: CYMBALTA is not recommended for patients
Duloxetine (Cymbalta) . Duloxetine (Cymbalta). Indications. Mechanism of Action. Pharmacokinetics. Adverse Effects. Dosing Guidelines. (Normal Renal.
Recommended Dose and Dose Adjustment. Adults Dosage for Patients with Renal Impairment: CYMBALTA is not recommended for patients with.
View duloxetine information, including dose, uses, side-effects, renal Duloxetine (Cymbalta ) for diabetic peripheral neuropathic pain in adults (September
For patients for whom tolerability is a concern, a lower starting dose may be considered. Since diabetes is frequently complicated by renal disease, a lower starting dose and gradual increase in dose should be considered for patients with renal impairment. Fibromyalgia - The recommended dose for Cymbalta is 60 mg administered once daily.
Therapeutics. Brands. Cymbalta. Generic Not recommended for use in patients with end-stage renal disease (requiring dialysis) or severe renal impairment
Limited data are available on the effects of CYMBALTA in patients with end-stage renal disease (ESRD). After a single. 60 mg dose of CYMBALTA, Cmax and AUC
duloxetine HCl. Cymbalta 20mg, 30mg, Renal impairment (CrCl 30–60mL/min): Reduce dose. (see full labeling); (CrCl 30mL/min or hemodialysis):. Dose with
Cymbalta is a medication for depression, anxiety, neuropathic pain and fibromyalgia. Learn about the recommended doses, adjustments and precautions for patients with renal impairment or end-stage renal disease.
Comments